ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cognitive and Memory Enhancer Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-11D8819
Home | Market Reports | Health| Pharmacy
China Cognitive and Memory Enhancer Drugs Market Report Forecast 2021 2027
BUY CHAPTERS

Global Cognitive and Memory Enhancer Drugs Market Research Report 2025

Code: QYRE-Auto-11D8819
Report
September 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Eisai Co Ltd
Allergan plc
Novartis
Takeda
Johnson & Johnson
Takeda Pharmaceutical Company Limited
AlternaScript LLC
Cephalon
Ceretropic

Cognitive and Memory Enhancer Drugs Market Size

The global market for Cognitive and Memory Enhancer Drugs was valued at US$ 4671 million in the year 2024 and is projected to reach a revised size of US$ 6498 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Cognitive and Memory Enhancer Drugs Market

Cognitive and Memory Enhancer Drugs Market

Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer"s disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cognitive and Memory Enhancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cognitive and Memory Enhancer Drugs.
The Cognitive and Memory Enhancer Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cognitive and Memory Enhancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cognitive and Memory Enhancer Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cognitive and Memory Enhancer Drugs Market Report

Report Metric Details
Report Name Cognitive and Memory Enhancer Drugs Market
Accounted market size in year US$ 4671 million
Forecasted market size in 2031 US$ 6498 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Aricept
  • Exelon
  • Namenda
  • Razadyne
  • Provigil
  • Ritalin
  • Adderall
  • Others
Segment by Application
  • Disease Treatment
  • Academic Performance
  • Athletic Performance
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Eisai Co, Allergan, Novartis, Takeda, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AlternaScript, Cephalon, Ceretropic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cognitive and Memory Enhancer Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cognitive and Memory Enhancer Drugs Market growing?

Ans: The Cognitive and Memory Enhancer Drugs Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Cognitive and Memory Enhancer Drugs Market size in 2031?

Ans: The Cognitive and Memory Enhancer Drugs Market size in 2031 will be US$ 6498 million.

Who are the main players in the Cognitive and Memory Enhancer Drugs Market report?

Ans: The main players in the Cognitive and Memory Enhancer Drugs Market are Pfizer, Eisai Co, Allergan, Novartis, Takeda, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AlternaScript, Cephalon, Ceretropic

What are the Application segmentation covered in the Cognitive and Memory Enhancer Drugs Market report?

Ans: The Applications covered in the Cognitive and Memory Enhancer Drugs Market report are Disease Treatment, Academic Performance, Athletic Performance, Others

What are the Type segmentation covered in the Cognitive and Memory Enhancer Drugs Market report?

Ans: The Types covered in the Cognitive and Memory Enhancer Drugs Market report are Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Aricept
1.2.3 Exelon
1.2.4 Namenda
1.2.5 Razadyne
1.2.6 Provigil
1.2.7 Ritalin
1.2.8 Adderall
1.2.9 Others
1.3 Market by Application
1.3.1 Global Cognitive and Memory Enhancer Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Disease Treatment
1.3.3 Academic Performance
1.3.4 Athletic Performance
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cognitive and Memory Enhancer Drugs Market Perspective (2020-2031)
2.2 Global Cognitive and Memory Enhancer Drugs Growth Trends by Region
2.2.1 Global Cognitive and Memory Enhancer Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cognitive and Memory Enhancer Drugs Historic Market Size by Region (2020-2025)
2.2.3 Cognitive and Memory Enhancer Drugs Forecasted Market Size by Region (2026-2031)
2.3 Cognitive and Memory Enhancer Drugs Market Dynamics
2.3.1 Cognitive and Memory Enhancer Drugs Industry Trends
2.3.2 Cognitive and Memory Enhancer Drugs Market Drivers
2.3.3 Cognitive and Memory Enhancer Drugs Market Challenges
2.3.4 Cognitive and Memory Enhancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cognitive and Memory Enhancer Drugs Players by Revenue
3.1.1 Global Top Cognitive and Memory Enhancer Drugs Players by Revenue (2020-2025)
3.1.2 Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Cognitive and Memory Enhancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cognitive and Memory Enhancer Drugs Revenue
3.4 Global Cognitive and Memory Enhancer Drugs Market Concentration Ratio
3.4.1 Global Cognitive and Memory Enhancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cognitive and Memory Enhancer Drugs Revenue in 2024
3.5 Global Key Players of Cognitive and Memory Enhancer Drugs Head office and Area Served
3.6 Global Key Players of Cognitive and Memory Enhancer Drugs, Product and Application
3.7 Global Key Players of Cognitive and Memory Enhancer Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cognitive and Memory Enhancer Drugs Breakdown Data by Type
4.1 Global Cognitive and Memory Enhancer Drugs Historic Market Size by Type (2020-2025)
4.2 Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Type (2026-2031)
5 Cognitive and Memory Enhancer Drugs Breakdown Data by Application
5.1 Global Cognitive and Memory Enhancer Drugs Historic Market Size by Application (2020-2025)
5.2 Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cognitive and Memory Enhancer Drugs Market Size (2020-2031)
6.2 North America Cognitive and Memory Enhancer Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cognitive and Memory Enhancer Drugs Market Size by Country (2020-2025)
6.4 North America Cognitive and Memory Enhancer Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cognitive and Memory Enhancer Drugs Market Size (2020-2031)
7.2 Europe Cognitive and Memory Enhancer Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2020-2025)
7.4 Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size (2020-2031)
8.2 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cognitive and Memory Enhancer Drugs Market Size (2020-2031)
9.2 Latin America Cognitive and Memory Enhancer Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cognitive and Memory Enhancer Drugs Market Size by Country (2020-2025)
9.4 Latin America Cognitive and Memory Enhancer Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size (2020-2031)
10.2 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cognitive and Memory Enhancer Drugs Introduction
11.1.4 Pfizer Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Eisai Co
11.2.1 Eisai Co Company Details
11.2.2 Eisai Co Business Overview
11.2.3 Eisai Co Cognitive and Memory Enhancer Drugs Introduction
11.2.4 Eisai Co Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.2.5 Eisai Co Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Cognitive and Memory Enhancer Drugs Introduction
11.3.4 Allergan Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.3.5 Allergan Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cognitive and Memory Enhancer Drugs Introduction
11.4.4 Novartis Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Cognitive and Memory Enhancer Drugs Introduction
11.5.4 Takeda Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.5.5 Takeda Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Cognitive and Memory Enhancer Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical Company Limited
11.7.1 Takeda Pharmaceutical Company Limited Company Details
11.7.2 Takeda Pharmaceutical Company Limited Business Overview
11.7.3 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Introduction
11.7.4 Takeda Pharmaceutical Company Limited Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.7.5 Takeda Pharmaceutical Company Limited Recent Development
11.8 AlternaScript
11.8.1 AlternaScript Company Details
11.8.2 AlternaScript Business Overview
11.8.3 AlternaScript Cognitive and Memory Enhancer Drugs Introduction
11.8.4 AlternaScript Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.8.5 AlternaScript Recent Development
11.9 Cephalon
11.9.1 Cephalon Company Details
11.9.2 Cephalon Business Overview
11.9.3 Cephalon Cognitive and Memory Enhancer Drugs Introduction
11.9.4 Cephalon Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.9.5 Cephalon Recent Development
11.10 Ceretropic
11.10.1 Ceretropic Company Details
11.10.2 Ceretropic Business Overview
11.10.3 Ceretropic Cognitive and Memory Enhancer Drugs Introduction
11.10.4 Ceretropic Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025)
11.10.5 Ceretropic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Eisai Co Ltd
Allergan plc
Novartis
Takeda
Johnson & Johnson
Takeda Pharmaceutical Company Limited
AlternaScript LLC
Cephalon
Ceretropic
List of Tables
 Table 1. Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Aricept
 Table 3. Key Players of Exelon
 Table 4. Key Players of Namenda
 Table 5. Key Players of Razadyne
 Table 6. Key Players of Provigil
 Table 7. Key Players of Ritalin
 Table 8. Key Players of Adderall
 Table 9. Global Cognitive and Memory Enhancer Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Cognitive and Memory Enhancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Cognitive and Memory Enhancer Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Cognitive and Memory Enhancer Drugs Market Share by Region (2020-2025)
 Table 13. Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Cognitive and Memory Enhancer Drugs Market Share by Region (2026-2031)
 Table 15. Cognitive and Memory Enhancer Drugs Market Trends
 Table 16. Cognitive and Memory Enhancer Drugs Market Drivers
 Table 17. Cognitive and Memory Enhancer Drugs Market Challenges
 Table 18. Cognitive and Memory Enhancer Drugs Market Restraints
 Table 19. Global Cognitive and Memory Enhancer Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Cognitive and Memory Enhancer Drugs Market Share by Players (2020-2025)
 Table 21. Global Top Cognitive and Memory Enhancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognitive and Memory Enhancer Drugs as of 2024)
 Table 22. Ranking of Global Top Cognitive and Memory Enhancer Drugs Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Cognitive and Memory Enhancer Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Cognitive and Memory Enhancer Drugs, Headquarters and Area Served
 Table 25. Global Key Players of Cognitive and Memory Enhancer Drugs, Product and Application
 Table 26. Global Key Players of Cognitive and Memory Enhancer Drugs, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Cognitive and Memory Enhancer Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2020-2025)
 Table 30. Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2026-2031)
 Table 32. Global Cognitive and Memory Enhancer Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Application (2020-2025)
 Table 34. Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Application (2026-2031)
 Table 36. North America Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Cognitive and Memory Enhancer Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Cognitive and Memory Enhancer Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Cognitive and Memory Enhancer Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Cognitive and Memory Enhancer Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Pfizer Company Details
 Table 52. Pfizer Business Overview
 Table 53. Pfizer Cognitive and Memory Enhancer Drugs Product
 Table 54. Pfizer Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 55. Pfizer Recent Development
 Table 56. Eisai Co Company Details
 Table 57. Eisai Co Business Overview
 Table 58. Eisai Co Cognitive and Memory Enhancer Drugs Product
 Table 59. Eisai Co Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 60. Eisai Co Recent Development
 Table 61. Allergan Company Details
 Table 62. Allergan Business Overview
 Table 63. Allergan Cognitive and Memory Enhancer Drugs Product
 Table 64. Allergan Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 65. Allergan Recent Development
 Table 66. Novartis Company Details
 Table 67. Novartis Business Overview
 Table 68. Novartis Cognitive and Memory Enhancer Drugs Product
 Table 69. Novartis Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 70. Novartis Recent Development
 Table 71. Takeda Company Details
 Table 72. Takeda Business Overview
 Table 73. Takeda Cognitive and Memory Enhancer Drugs Product
 Table 74. Takeda Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 75. Takeda Recent Development
 Table 76. Johnson & Johnson Company Details
 Table 77. Johnson & Johnson Business Overview
 Table 78. Johnson & Johnson Cognitive and Memory Enhancer Drugs Product
 Table 79. Johnson & Johnson Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 80. Johnson & Johnson Recent Development
 Table 81. Takeda Pharmaceutical Company Limited Company Details
 Table 82. Takeda Pharmaceutical Company Limited Business Overview
 Table 83. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Product
 Table 84. Takeda Pharmaceutical Company Limited Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 85. Takeda Pharmaceutical Company Limited Recent Development
 Table 86. AlternaScript Company Details
 Table 87. AlternaScript Business Overview
 Table 88. AlternaScript Cognitive and Memory Enhancer Drugs Product
 Table 89. AlternaScript Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 90. AlternaScript Recent Development
 Table 91. Cephalon Company Details
 Table 92. Cephalon Business Overview
 Table 93. Cephalon Cognitive and Memory Enhancer Drugs Product
 Table 94. Cephalon Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 95. Cephalon Recent Development
 Table 96. Ceretropic Company Details
 Table 97. Ceretropic Business Overview
 Table 98. Ceretropic Cognitive and Memory Enhancer Drugs Product
 Table 99. Ceretropic Revenue in Cognitive and Memory Enhancer Drugs Business (2020-2025) & (US$ Million)
 Table 100. Ceretropic Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Cognitive and Memory Enhancer Drugs Picture
 Figure 2. Global Cognitive and Memory Enhancer Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cognitive and Memory Enhancer Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Aricept Features
 Figure 5. Exelon Features
 Figure 6. Namenda Features
 Figure 7. Razadyne Features
 Figure 8. Provigil Features
 Figure 9. Ritalin Features
 Figure 10. Adderall Features
 Figure 11. Others Features
 Figure 12. Global Cognitive and Memory Enhancer Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Cognitive and Memory Enhancer Drugs Market Share by Application: 2024 VS 2031
 Figure 14. Disease Treatment Case Studies
 Figure 15. Academic Performance Case Studies
 Figure 16. Athletic Performance Case Studies
 Figure 17. Others Case Studies
 Figure 18. Cognitive and Memory Enhancer Drugs Report Years Considered
 Figure 19. Global Cognitive and Memory Enhancer Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Cognitive and Memory Enhancer Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Cognitive and Memory Enhancer Drugs Market Share by Region: 2024 VS 2031
 Figure 22. Global Cognitive and Memory Enhancer Drugs Market Share by Players in 2024
 Figure 23. Global Top Cognitive and Memory Enhancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognitive and Memory Enhancer Drugs as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Cognitive and Memory Enhancer Drugs Revenue in 2024
 Figure 25. North America Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Cognitive and Memory Enhancer Drugs Market Share by Country (2020-2031)
 Figure 27. United States Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Cognitive and Memory Enhancer Drugs Market Share by Country (2020-2031)
 Figure 31. Germany Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Share by Region (2020-2031)
 Figure 39. China Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Cognitive and Memory Enhancer Drugs Market Share by Country (2020-2031)
 Figure 47. Mexico Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Share by Country (2020-2031)
 Figure 51. Turkey Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Pfizer Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 55. Eisai Co Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 56. Allergan Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 57. Novartis Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 58. Takeda Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 59. Johnson & Johnson Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 60. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 61. AlternaScript Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 62. Cephalon Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 63. Ceretropic Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions